日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A tumor-promoting inflammatory SPP1+ macrophage-IL-6-CRP axis drives immune dysfunction in bladder cancer

肿瘤促进性炎症SPP1+巨噬细胞-IL-6-CRP轴驱动膀胱癌免疫功能障碍

Tran, Michelle A; Cho, Byuri Angela; Izadmehr, Sudeh; Yoo, Seong-Keun; Youssef, Dina; Anker, Jonathan F; Farkas, Adam M; Figueiredo, Igor; Lee, Karen; Ananthanarayanan, Aparna; Balan, Sreekumar; Onkar, Sayali; Banchereau, Romain; Gupta, Saurabh; Chhibber, Aparna; Wang, Li; Beaumont, Kristin G; Li, Ziao; Garcia-Barros, Monica; Bicak, Mesude; Cordon-Cardo, Carlos; Brody, Rachel; Kim-Schulze, Seunghee; Yuen, Kobe; Mariathasan, Sanjeev; Atiq, Saad O; Adeyelu, Tolulope T; Elliott, Andrew; Barata, Pedro; McKay, Rana R; Gnjatic, Sacha; Gonzalez-Kozlova, Edgar; Mehrazin, Reza; Horowitz, Amir; Sfakianos, John P; Chowell, Diego; Galsky, Matthew D; Bhardwaj, Nina

Phase 2 trial of pTVG-HP ± pTVG-AR DNA vaccines and pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC)

pTVG-HP ± pTVG-AR DNA 疫苗和帕博利珠单抗治疗转移性去势抵抗性前列腺癌 (mCRPC) 患者的 II 期试验

Kyriakopoulos, Christos E; Pachynski, Russell K; Eickhoff, Jens C; Tonelli, Tommaso P; Jeon, Donghwan; McNeel, Douglas G

Comparison of complications and oncology outcomes of immunotherapy alone and combination in metastatic castration-resistant prostate cancer (mCRPC): a systematic review and meta-analysis

转移性去势抵抗性前列腺癌(mCRPC)单用免疫疗法与联合免疫疗法并发症及肿瘤学疗效的比较:系统评价和荟萃分析

Liu, Jun; Kang, Yong-Ming; Feng, You-Gang; Zhang, Cai; Chen, Wen-Zhi

Letter to the editor: Development and validation of a machine learning-based risk model for metastatic disease in nmCRPC patients: a tumor marker prognostic study

致编辑的信:基于机器学习的转移性疾病非转移性去势抵抗性前列腺癌(nmCRPC)患者风险模型的开发与验证:一项肿瘤标志物预后研究

Jin, Yushan; Fang, Yuan; Yao, Yao

Quantitative dual-tracer PET/CT biomarkers correlate concordant lesion uptake with PSMA-RLT outcomes in mCRPC: a dual-center study

定量双示踪剂PET/CT生物标志物将病灶摄取一致性与mCRPC患者的PSMA-RLT疗效相关联:一项双中心研究

Xue, Song; Einspieler, Holger; Wen, Sijie; Muin, Dina; Nikolic, Ana Antic; Baessler, Jan; Kramer, Gero; Shariat, Shahrokh F; Lapa, Constantin; Hacker, Marcus; Rasul, Sazan; Li, Xiang

Bellmunt risk score enables survival prediction in men with metastatic castration resistant prostate cancer (mCRPC) undergoing PSMA-targeted radioligand therapy (LUMEN)

Bellmunt 风险评分能够预测接受 PSMA 靶向放射性配体治疗的转移性去势抵抗性前列腺癌 (mCRPC) 患者的生存情况 (LUMEN)

Büttner, Thomas; Marinova, Milka; Gaertner, Florian C; Kreppel, Barbara; Fritsche, Leander; Immanuel, Christian; Geraths, Gerd; Kürpig, Stefan; Küppers, Jim; Schmidt-Wolf, Ingo G H; Essler, Markus; Ritter, Manuel; Krausewitz, Philipp

Metabolic reprogramming induced by CRP deficiency or human CRP transgenic in influenza-infected mice

流感病毒感染小鼠中,CRP 缺乏或人 CRP 转基因诱导的代谢重编程

Luo, Junhao; Zhang, Zhuohan; Zhao, Song; Pu, Siyu; Li, Li; Gao, Rongbao

Age-dependent patterns of inflammatory and autoimmune markers: CRP-RF correlation emerges after age 50 in asymptomatic adults

炎症和自身免疫标志物的年龄依赖性模式:CRP-RF相关性在50岁以后出现在无症状成年人中

Suliman, Bandar A

Mind the "CRP gender gap"! sex differences in CRP evolution over time in neonatal sepsis: a monocentric retrospective cohort study

注意“CRP性别差异”!新生儿败血症中CRP随时间变化的性别差异:一项单中心回顾性队列研究

Nebbioso, Andrea; Eggermont, Isaline; Vicinanza, Alfredo; Lê, Phu-Quoc; Vitali, Nancy; Augé, Gwenaëlle; Lefèvre, Nicolas

Is three-phase bone scintigraphy really obsolete? : a combined TPBS-CRP diagnostic method

三相骨显像真的过时了吗?:一种联合TPBS-CRP诊断方法

Chen, Quan; Li, Yicheng; Guo, Xiaobin; Wlamu, Wuhuzi; Mu, Wenbo; Ji, Baochao; Cao, Li; Zhang, Xiaogang